PRIMARY NEUROENDOCRINE TUMOR OF THE ENDOMETRIUM, A RARE TUMOR: CASE SERIES
DOI:
https://doi.org/10.22159/ijcpr.2025v17i1.6044Keywords:
Neuroendocrine tumor, Endometrial NETs, Small cell neuroendocrine carcinomaAbstract
Objective: Endometrial NET is a rare disease with a poor prognosis. Due to its rarity, there are no evidence-based standards or international guidelines for the diagnosis and treatment of endometrial NETs.
Methods: In this study, we present our experience with four cases of NETs of the endometrium to describe these rare tumors’ clinical characteristics and behaviour. The clinicopathological characteristics, treatment and prognosis, were analysed.
Results: Most common age group for presentation was 50 to 70 y. Irregular vaginal bleeding was most common symptom at presentation. Three patients underwent surgery followed by adjuvant chemoradiation while one patient with metastatic disease underwent chemotherapy. Overall prognosis was poor with two patients died 12 mo and 24 mo, respectively. One patient was lost to follow-up after 39 mo and one patient was disease free till last follow-up.
Conclusion: Given the aggressive nature of the disease, patients should be carefully observed and followed up regularly. More studies with a higher number of cases are required to establish a standard therapeutic protocol.
Downloads
References
Rouzbahman M, Clarke B. Neuroendocrine tumors of the gynecologic tract: select topics. Semin Diagn Pathol. 2013;30(3):224-33. doi: 10.1053/j.semdp.2013.06.007, PMID 24144291.
Atienza Amores M, Guerini Rocco E, Soslow RA, Park KJ, Weigelt B. Small cell carcinoma of the gynecologic tract: a multifaceted spectrum of lesions. Gynecol Oncol. 2014;134(2):410-8. doi: 10.1016/j.ygyno.2014.05.017, PMID 24875120.
Van Hoeven KH, Hudock JA, Woodruff JM, Suhrland MJ. Small cell neuroendocrine carcinoma of the endometrium. Int J Gynecol Pathol. 1995;14(1):21-9. doi: 10.1097/00004347-199501000-00005, PMID 7883422.
Huntsman DG, Clement PB, Gilks CB, Scully RE. Small cell carcinoma of the endometrium a clinicopathological study of sixteen cases. Am J Surg Pathol. 1994;18(4):364-75. doi: 10.1097/00000478-199404000-00005, PMID 7511354.
Mulvany NJ, Allen DG. Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium. Int J Gynecol Pathol. 2008;27(1):49-57. doi: 10.1097/pgp.0b013e31806219c5, PMID 18156975.
Terada T. Large cell neuroendocrine carcinoma with sarcomatous changes of the endometrium: a case report with immunohistochemical studies and molecular genetic study of KIT and PDGFRA. Pathol Res Pract. 2010;206(6):420-5. doi: 10.1016/j.prp.2009.12.008, PMID 20189318.
Deodhar KK, Kerkar RA, Suryawanshi P, Menon H, Menon S. Large cell neuroendocrine carcinoma of the endometrium: an extremely uncommon diagnosis but worth the efforts. J Cancer Res Ther. 2011;7(2):211-3. doi: 10.4103/0973-1482.82942, PMID 21768718.
Shahabi S, Pellicciotta I, Hou J, Graceffa S, Huang GS, Samuelson RN. Clinical utility of chromogranin a and octreotide in large cell neuro endocrine carcinoma of the uterine corpus. Rare Tumors. 2011 Oct 11;3(4):e41. doi: 10.4081/rt.2011.e41, PMID 22355496.
FIGO Committee on Gynecologic Oncology. FIGO staging for carcinoma of the vulva cervix and corpus uteri. Int J Gynaecol Obstet. 2014;125(2):97-8. doi: 10.1016/j.ijgo.2014.02.003, PMID 24630859.
Melgoza F, Brewster WR, Wilczynski S, Rutgers J. p16-Positive small cell neuroendocrine carcinoma of the endometrium. Int J Gynecol Pathol. 2006;25(3):252-6. doi: 10.1097/01.pgp.0000189242.11404.ae, PMID 16810063.
Terada T. KIT-positive primary small cell carcinoma of the endometrium: a case report with immunohistochemical and molecular genetic analysis of KIT and PDGFRA genes. Arch Gynecol Obstet. 2010;282(4):413-6. doi: 10.1007/s00404-009-1324-5, PMID 20035340.
Published
How to Cite
Issue
Section
Copyright (c) 2025 PRATEEK TIWARI, SHREENA PATIDAR, V. PAL
This work is licensed under a Creative Commons Attribution 4.0 International License.
